Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
31 3월 2025 - 9:31PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-163
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of March 2025
Alterity
Therapeutics Limited
(Name
of Registrant)
Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980
and 333-228671) and our
Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417
and 333-250076)
ALTERITY
THERAPEUTICS LIMITED
(a
development stage enterprise)
The
following exhibits are submitted:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Alterity Therapeutics Limited |
|
|
|
|
By: |
/s/ Geoffrey P. Kempler |
|
|
Geoffrey P. Kempler |
|
|
Chairman |
Date:
March 31, 2025
2
Exhibit 99.1
Disclosure of Proxy Votes
Alterity Therapeutics Limited
Extraordinary General Meeting
Monday, 31 March 2025 |

GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 |
In accordance with section 251AA of the Corporations Act
2001, the following information is provided in relation to resolutions put to members at the meeting.
|
Proxy
Votes |
Poll
Results (if
applicable) |
Results |
Resolution |
Decided by
Show of
Hands (S) or
Poll (P) |
Total
Number of
Proxy Votes
exercisable by
proxies validly
appointed |
FOR |
AGAINST |
ABSTAIN |
PROXY’S
DISCRETION |
FOR |
AGAINST |
ABSTAIN |
OUTCOME |
1
Ratification of prior issue of Shares |
P |
782,564,458 |
657,057,386
83.96% |
92,500,708
11.82% |
1,534,571 |
33,006,364
4.22% |
700,829,750
88.34% |
92,500,708
11.66% |
1,534,571 |
Carried |
2
Ratification of prior issue of Shares |
P |
467,191,617 |
341,671,945
73.13% |
92,513,308
19.80% |
1,654,571 |
33,006,364
7.06% |
385,444,309
80.64% |
92,513,308
19.36% |
1,654,571 |
Carried |
3
Approval for issue of Shares |
P |
1,028,650,344 |
928,398,161
90.25% |
66,938,959
6.51% |
1,027,200 |
33,313,224
3.24% |
972,477,385
93.56% |
66,938,959
6.44% |
1,027,200 |
Carried |
4
Approval for issue of Options |
P |
457,078,417 |
353,933,151
77.43% |
69,832,042
15.28% |
4,082,971 |
33,313,224
7.29% |
398,012,375
85.07% |
69,832,042
14.93% |
4,082,971 |
Carried |
5A
Approval for issue of Securities – Placement – Peter Marks |
P |
1,033,783,401 |
967,829,394
93.62% |
36,790,262
3.56% |
3,037,000 |
29,163,745
2.82% |
1,007,759,139
96.48% |
36,790,262
3.52% |
3,037,000 |
Carried |
5B
Approval for issue of Securities – Placement – Brian Meltzer |
P |
1,033,610,512 |
968,680,105
93.72% |
35,766,662
3.46% |
3,055,000 |
29,163,745
2.82% |
1,008,609,850
96.58% |
35,766,662
3.42% |
3,055,000 |
Carried |
5C
Approval for issue of Securities – Placement – Lawrence Gozlan |
P |
1,039,426,769 |
973,338,362
93.64% |
36,924,662
3.55% |
3,055,000 |
29,163,745
2.81% |
1,013,268,107
96.48% |
36,924,662
3.52% |
3,055,000 |
Carried |
6
Approval for issue of Options |
P |
1,013,470,209 |
924,677,848
91.24% |
49,802,116
4.91% |
30,536,160 |
38,990,245
3.85% |
974,434,093
95.14% |
49,802,116
4.86% |
30,536,160 |
Carried |

|
Proxy
Votes |
Poll
Results (if
applicable) |
Results |
Resolution |
Decided
by
Show of
Hands (S) or
Poll (P) |
Total
Number of
Proxy Votes
exercisable by
proxies validly
appointed |
FOR |
AGAINST |
ABSTAIN |
PROXY’S
DISCRETION |
FOR |
AGAINST |
ABSTAIN |
OUTCOME |
7
Approval to refresh and amend 2004 ASX Plan |
P |
1,039,321,019 |
908,349,072
87.40% |
97,974,583
9.43% |
4,684,750 |
32,997,364
3.17% |
935,463,691
90.52% |
97,974,583
9.48% |
5,440,750 |
Carried |
8 Approval to refresh and amend 2018 ADS Plan |
P |
1,039,310,819 |
910,329,672
87.59% |
95,983,783
9.24% |
4,685,950 |
32,997,364
3.17% |
938,200,291
90.72% |
95,983,783
9.28% |
4,685,950 |
Carried |

Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025